Previous 10 | Next 10 |
2024-04-10 17:27:45 ET More on AVITA Medical AVITA Medical: Unconvincing Growth Amid Fierce Competition In The Burn Care Sector AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Call Transcript AVITA Medical Q4 2023 Earnings Preview Cantor picks RCEL as best 2024 m...
VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced an update to its expected commercial revenue for th...
2024-04-04 08:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-25 06:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced it has submitted its response to the U.S. Food and D...
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that David O’Toole, Chief Financial Officer, ...
2024-02-22 23:03:08 ET AVITA Medical, Inc. (RCEL) Q4 2023 Earnings Conference Call February 22, 2024 04:30 PM ET Company Participants Jessica Ekeberg - Director, IR Jim Corbett - CEO David O'Toole - CFO Conference Call Participants Brooks O'Neil - Lak...
2024-02-22 16:30:39 ET More on AVITA Medical AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum AVITA Medical Q4 2023 Earnings Preview Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS Seeking Alpha’s ...
VALENCIA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the fourth quarter and full-yea...
2024-02-21 12:16:33 ET More on AVITA Medical AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS Avita Medical misses Q4, FY23 prelim revenue estimate Seeking ...
News, Short Squeeze, Breakout and More Instantly...
VALENCIA, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its second quarter 2024 financia...
VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M. Still Burn Center at Doctors Hosp...
2024-06-02 14:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...